BACKGROUND AND AIMS: Various markers are used to monitor disease activity in paediatric Crohn's disease (CD). We sought to determine whether C-reactive protein measurement was useful in the assessment of disease activity in children with CD, with comparison to the other markers of disease activity. METHODS: Details of disease activity, C-reactive protein and inflammatory markers were obtained retrospectively from the records of 100 outpatient visits by 63 children with CD. RESULTS: The children were 12.6 (+/-3.4) years of age. C-reactive protein values correlated positively with disease activity (P < 0.0001). Children with inactive disease (according to pediatric CD activity index scores) had significantly lower C-reactive protein values compared to children with mild disease (P < 0.001). In addition, C-reactive protein values correlated well with ESR (P < 0.0001). Conclusions C-reactive protein measurements provided useful information in assessing children with CD and correlated well with a validated measure of disease activity.
BACKGROUND AND AIMS: Various markers are used to monitor disease activity in paediatric Crohn's disease (CD). We sought to determine whether C-reactive protein measurement was useful in the assessment of disease activity in children with CD, with comparison to the other markers of disease activity. METHODS: Details of disease activity, C-reactive protein and inflammatory markers were obtained retrospectively from the records of 100 outpatient visits by 63 children with CD. RESULTS: The children were 12.6 (+/-3.4) years of age. C-reactive protein values correlated positively with disease activity (P < 0.0001). Children with inactive disease (according to pediatric CD activity index scores) had significantly lower C-reactive protein values compared to children with mild disease (P < 0.001). In addition, C-reactive protein values correlated well with ESR (P < 0.0001). Conclusions C-reactive protein measurements provided useful information in assessing children with CD and correlated well with a validated measure of disease activity.
Authors: Anne M Griffiths; Anthony R Otley; Jeffrey Hyams; Antonio R Quiros; Richard J Grand; Athos Bousvaros; Brian G Feagan; George R Ferry Journal: Inflamm Bowel Dis Date: 2005-02 Impact factor: 5.325
Authors: Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren Journal: Can J Gastroenterol Date: 2005-09 Impact factor: 3.522
Authors: Jost Langhorst; Sigrid Elsenbruch; Julia Koelzer; Andreas Rueffer; Andreas Michalsen; Gustav J Dobos Journal: Am J Gastroenterol Date: 2007-10-04 Impact factor: 10.864
Authors: Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths Journal: J Pediatr Gastroenterol Nutr Date: 2005-10 Impact factor: 2.839
Authors: Andrew S Day; Kylie E Whitten; Daniel A Lemberg; Cathy Clarkson; Maribel Vitug-Sales; Reuben Jackson; Tim D Bohane Journal: J Gastroenterol Hepatol Date: 2006-10 Impact factor: 4.029
Authors: Harland S Winter; Peter T Masiakos; Christopher J Moran; Jess L Kaplan Journal: J Pediatr Gastroenterol Nutr Date: 2015-07 Impact factor: 2.839
Authors: Aleksandra Glapa-Nowak; Mariusz Szczepanik; Aleksandra Banaszkiewicz; Jarosław Kwiecień; Anna Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Jarosław Kierkuś; Marcin Dziekiewicz; Jarosław Walkowiak Journal: Med Sci Monit Date: 2022-09-14